dpp 4 inhibitor and glp 1 agonist How does sitagliptin work? DPP-4 inhibitors GLP-1 mimetics Mechanisms of dipeptidyl peptidase‐4 (DPP‐4)
Description
Whether these results demonstrate the ceiling for pharmacologically targeting body weight has yet to be met

Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire

Christian Wber: has received honoraria consultancy/speaking from Apomedica, Curelator, Eli Lilly, Grnenthal, Hermes, Lundbeck, Novartis, Pfizer, Ratiopharm/Teva, and Stada

Multiple studies have demonstrated beneficial reductions in weight and HbA 1c with short acting GLP-1 RA in individuals with overweight or obesity and type 1 diabetes [45,46,47,48]

P., Engstrom, T

Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Pilitsi E, et al
